These results show that LIF and IL-6 signals likely regulate the SOCS3 system in the placenta, but IL-6 signals more likely affect the induction of SOC3 because the expression of Socs3 in the placenta correlates well with IL-6 level in MS (Fig 5F). The gene discussed is SOCS3; the disease is myeloid sarcoma.